Its AI deal-making activity highlights some areas where the tech is picking up steam in healthcare.
For example, at the end of 2023, it backed a round for genAI-powered clinical documentation startup Abridge.
Other evaluated health systems that have backed Abridge include Kaiser Permanente, Mass General Brigham, UPMC, and Lifepoint Health.
The company is part of a broader cohort of genAI copilots gaining attention for helping doctors speed up admin tasks like note-taking.
Dive deeper into the space here.
Not: Early-stage digital health deals
There is markedly less early-stage activity in digital health in 2024.
YTD, we’re at 51%.
Historically, early-stage deals have been ~65% of deals.